Skip to content
Buy This GLP
← Research
Evidence

Why Do Some People Lose Less Weight on a GLP-1?

Two observational studies illustrate why weight changes vary and why blood sugar and body composition can move differently.

Editorial profile: Carla MedinaBuy This GLP Editorial Team10 min read
What “it worked” meant, in 166 patientsblood sugar only53%blood sugar AND fat mass29.5%little or no response12%fat mass only5.4%Results across several metformin-based regimens.

A medical-record study found different weight-loss outcomes among people taking semaglutide or tirzepatide (n = 135,349) [1]. The guide to how long GLP-1 effects take explains why the timing of measurement matters. The records study grouped people by measured weight change.

What might explain differences?

The study found associations with treatment formulation and patient characteristics. Dose, the reason for prescribing and differences between patient groups can all affect comparisons from records. Researchers did not assign treatments at random.

Does response always mean losing weight?

In a separate clinic cohort, researchers followed adults with type 2 diabetes on stable metformin-based regimens (n = 166). About 53% improved on their blood-sugar measure while falling short of the study's fat-mass threshold [2]. Our guide to changes in body composition on GLP-1 treatment explains why weight and tissue measures differ. The clinic result pooled several treatment types.

Frequently asked

Does weight tell the whole story?
In a small cohort of adults with type 2 diabetes, many improved on the blood-sugar measure without meeting the fat-mass threshold. There were multiple treatment groups.

Sources

  1. [1] Venkatakrishnan AJ, Murugadoss K, Soundararajan V (2026). Decoding the hallmarks of GLP-1RA weight-loss super-responders Biology Methods & Protocols. PMID 42147968
  2. [2] Bujdei-Tebeică I, Pantea-Stoian AM, Mihai DA, Ștefan SD, et al. (2026). Patient-Level Multidimensional Response Phenotypes in Obesity-Associated Type 2 Diabetes: A 12-Month Real-World Cohort Study Journal of Clinical Medicine. PMID 42513584

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence